Crossmark

The Efficacy and Safety of Lurasidone in Adolescent Patients with Schizophrenia: Results of Functional and Quality of Life Measures from a 6-week, Double-blind, Placebo-controlled Study

Crossref DOI link: https://doi.org/10.1016/j.eurpsy.2017.01.292

Published Online: 2020-03-23

Published Print: 2017-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Findling, R.

Goldman, R.

Cucchiaro, J.

Deng, L.

Loebel, A.
License Information

License valid from 2020-03-23

Text and Data Mining valid from 2017-04-01
More Information

This article is maintained by: Elsevier

Article Title: The efficacy and safety of lurasidone in adolescent patients with schizophrenia: Results of functional and quality of life measures from a 6-week, double-blind, placebo-controlled study

Journal Title: European Psychiatry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eurpsy.2017.01.292

Content Type: simple-article

Copyright: Copyright © 2017 Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below